Cell Stem Cell

Cell Stem Cell is a peer-reviewed journal published by Cell Press, an imprint of Elsevier, founded in 2007 at the dawn of the human iPS era and covering stem cell science, in vitro tissue modeling and regenerative medicine, with a 2025 Journal Impact Factor of 23.3《细胞·干细胞》是由（Elsevier）旗下（Cell Press）出版、2007 年在人类诱导多能干细胞时代之初创办的同行评审期刊，涵盖干细胞科学、体外组织建模与再生医学，2025 年影响因子为 23.3。

Scope

• It publishes bold advances in stem cell science, in vitro tissue modeling, the integration of biomaterials with living systems and regenerative medicine该刊刊载干细胞科学、体外组织建模、生物材料与生命系统整合以及再生医学方面的重大进展。
• It prioritizes studies that ground their findings in human biology, disease insights and physiological relevance该刊优先发表将发现建立于人类生物学、疾病认识与生理相关性之上的研究。
• It covers the fundamental science of stem cells in driving disease, aging, regeneration, wound healing and fibrosis该刊涵盖干细胞在疾病、衰老、再生、伤口愈合与纤维化中所起作用的基础科学。
• It is highly interested in in vitro human tissue models such as organoids, assembloids, organ-chips and bioprinted tissues该刊高度关注类器官、组装体、器官芯片与生物打印组织等体外人体组织模型。
• It seeks work integrating biomaterials to improve stem cell culture, tissue engineering and graft survival and function in vivo该刊期待融合生物材料以改进干细胞培养、组织工程以及移植物体内存活与功能的研究。
• It covers cell and gene therapies using stem cells, primary cells or immunotherapies and the methodological work that moves these therapies towards patients该刊涵盖利用干细胞、原代细胞或免疫疗法的细胞与基因治疗，以及推动这些疗法走向患者的方法学研究。

History

• The journal was established in 2007 by Cell Press at the dawn of the human induced pluripotent stem cell era该刊由（Cell Press）于 2007 年创办，时值人类诱导多能干细胞时代之初。^[1]
• Its founding editor-in-chief was Deborah J. Sweet, who had previously worked as an editor on journals including Cell and Developmental Cell其创刊主编为 Deborah J. Sweet，此前曾在（Cell）与（Developmental Cell）等期刊担任编辑。
• Deborah J. Sweet led the journal for about ten years before handing over the editorshipDeborah J. Sweet 执掌该刊约十年后交棒。
• The journal has been published monthly since its launch and forms part of the Cell Press portfolio该刊自创刊起按月刊出版，是（Cell Press）刊群的一员。
• Its 2025 Journal Impact Factor is 23.3, and it ranks first among 32 journals in the cell and tissue engineering category其 2025 年影响因子为 23.3，在细胞与组织工程类别的 32 种期刊中排名第一。

Editors

• The editor-in-chief is Sheila Chari, who leads the journal at Cell Press现任主编为 Sheila Chari 博士，在（Cell Press）执掌该刊。
• Sheila Chari trained as a research scientist before joining Cell Press as an editorSheila Chari 在加入（Cell Press）担任编辑之前受过科研训练。
• The journal's approach to peer review is collaborative and constructive, with cross-consultation among reviewers该刊的同行评审方式注重协作与建设性，评审人之间会相互协商。
• Its reviews and commentaries debate the scientific, ethical and regulatory issues of stem cell research该刊的综述与评论文章探讨干细胞研究中的科学、伦理与监管议题。
• It seeks to act as a steward for the field and to help make the promise of stem cells a reality该刊力图充当该领域的守护者，助力干细胞的前景成为现实。